291 related articles for article (PubMed ID: 23876794)
1. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
2. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
3. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
Imran M; Park TJ; Lim IK
Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
[TBL] [Abstract][Full Text] [Related]
4. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
5. B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating IκBα degradation in normal and cancer cells.
Sundaramoorthy S; Ryu MS; Lim IK
Cell Commun Signal; 2013 Sep; 11():69. PubMed ID: 24047462
[TBL] [Abstract][Full Text] [Related]
6. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
Lim YB; Park TJ; Lim IK
J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
[TBL] [Abstract][Full Text] [Related]
7. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
[TBL] [Abstract][Full Text] [Related]
9. TIS21
Lim IK; Choi JA; Kim EY; Kim BN; Jang S; Ryu MS; Shim SH
Cell Signal; 2017 Jan; 30():179-190. PubMed ID: 27932314
[TBL] [Abstract][Full Text] [Related]
10. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
11. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
12. Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-kappaB.
Jang BC; Jung TY; Paik JH; Kwon YK; Shin SW; Kim SP; Ha JS; Suh MH; Suh SI
Biochem Biophys Res Commun; 2005 Mar; 328(1):70-7. PubMed ID: 15670752
[TBL] [Abstract][Full Text] [Related]
13. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
el-Ghissassi F; Valsesia-Wittmann S; Falette N; Duriez C; Walden PD; Puisieux A
Oncogene; 2002 Oct; 21(44):6772-78. PubMed ID: 12360398
[TBL] [Abstract][Full Text] [Related]
14. Expression of B-cell translocation gene 2 protein in normal human tissues.
Melamed J; Kernizan S; Walden PD
Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
[TBL] [Abstract][Full Text] [Related]
15. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
[TBL] [Abstract][Full Text] [Related]
16. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
[TBL] [Abstract][Full Text] [Related]
17. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
[TBL] [Abstract][Full Text] [Related]
19. BTG2: a rising star of tumor suppressors (review).
Mao B; Zhang Z; Wang G
Int J Oncol; 2015 Feb; 46(2):459-64. PubMed ID: 25405282
[TBL] [Abstract][Full Text] [Related]
20. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
